Patterns of use, dosing, and economic impact of biologic agent use in patients with rheumatoid arthritis: a retrospective cohort study

BACKGROUND: Variability in dosing and costs of biologics among patients with rheumatoid arthritis (RA) is of interest to healthcare descision-makers. We examined dosing and costs among RA patients newly treated with infliximab or etanercept under conditions of typical clinical practice. METHODS: Int...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilbert, Thomas D, Smith, Daniel, Ollendorf, Daniel A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC526206/
https://www.ncbi.nlm.nih.gov/pubmed/15485582
http://dx.doi.org/10.1186/1471-2474-5-36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC526206/
https://www.ncbi.nlm.nih.gov/pubmed/15485582
http://dx.doi.org/10.1186/1471-2474-5-36

Ejemplares similares